<DOC>
	<DOCNO>NCT02055313</DOCNO>
	<brief_summary>The main objective study explore experience insight exceptional patient , patient cancer consider physician exceptional course survival relate specific disease state . A secondary future objective study develop international multicenter registry database document examine experience patient cancer consider physician exceptional course survival relate specific disease state .</brief_summary>
	<brief_title>Perceptions Exceptional Patients Cancer Care Relating Their Unusual Survival</brief_title>
	<detailed_description>This pilot study utilize population registry one location ( Israel ) identify exceptional patient one terminal disease . Pancreatic malignancy , advanced lung cancer ; advanced stomach cancer advance esophageal cancer choose specific terminal disease , base extremely high mortality rate . These specific situation apply strict definition set Gotay : `` An exceptional survivor cancer patient alive probability le 25 % living five year , give type stage . '' [ 48 ] These type cancer associate 5 year survival le 15 % even late technology advance cancer care ; slight improvement survival patient . The study divide three stage : 1 . Identifying patient Clalit HMO approach obtain ethical committee 's approval study access HMO registry . Clalit HMO large HMO Israel 4 million member ( total population 7.5 million ) . After secure approval , patient identify HMO registry . We try identify patient diagnosis pancreatic cancer advance lung cancer , advance stomach cancer advance esophageal cancer still alive 2001-2008 . Each patient 's physician contact verify diagnosis correct . The physician ask contact patient obtain consent participate study . Consenting patient sent letter sign primary physician describes study indicate someone call invite participate study . The letter clarify participation completely voluntary decline participate affect way . 2 . Approaching patient Patients consent participate study contact qualitative researcher ( SG ) interview follow qualitative study protocol 3 . Analysis finding preparation summary report .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>18 year age old Ability speak read Hebrew , English Russian . Diagnosis pancreatic adenocarcinoma advance lung cancer , advance stomach cancer advance esophageal cancer confirm treat physician , laboratory test medical image technique . Pancreatic adenocarcinoma patient advance lung cancer , advance stomach cancer advance esophageal cancer patient alive probability le 15 % . Consent participate study Inability understand intent study Medical condition would preclude participation interview session last 30 minute Diagnosis active psychosis severe cognitive impairment confirm patient 's attend physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Exceptional patient</keyword>
	<keyword>Cancer care</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Pancreatic cancer</keyword>
	<keyword>Stomach cancer</keyword>
	<keyword>Unexplained survival</keyword>
	<keyword>still alive 2001-2008</keyword>
</DOC>